Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Clicks: 287
ID: 6605
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
69.5
/100
287 views
236 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #40 of 194 articles by views in journal of hepatocellular carcinoma
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 194 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (19 words).
Try re-searching for a better abstract.
| Reference Key |
nicholas2019prospectivejournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nicholas Fidelman;Curt Johanson;Maureen P Kohi;K Pallav Kolli;Ryan M Kohlbrenner;Evan D Lehrman;Andrew G Taylor;R Kate Kelley;Francis Y Yao;John P Roberts;Robert K Kerlan and |
| Journal | journal of hepatocellular carcinoma |
| Year | 2019 |
| DOI |
10.2147/JHC.S206979
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.